The drug firm reported a 3.22 percent increase in net profit to Rs. 36.2 crore for the quarter ended September 30 as sales rose.
first published: Oct 21, 2013 01:38 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty extend surge to third day led by banking, IT stocks | Closing Bell
Tata Capital's Mega Rs 15,500 Cr IPO Kicks Off| Management On Future Outlook| IPO Watch Live
Live: Big IPOs, Q2 earnings season: Markets enter action-packed week | Opening Bell
The 23-Year-Old Struggling It Out As A Real Estate Broker | The Tenant
